. Author manuscript; available in PMC: 2012 Jun 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2009 Mar;15(3):360–366. doi: 10.1016/j.bbmt.2008.12.495

Table 2.

Multivariate analysis for relapse in children who were diagnosed with AML (N=156) and received unrelated donor BMT.

Variables	N	Odds Ratio (95% Confidence Interval )	P-value
HLA matching
(1) Matched	69	1.00 ^a
(2) 7/8 matched	87	0.63 (0.26, 1.55)	0.36
Other significant covariates:
Grade III-IV aGVHD
(1) No	89	1.00 ^a
(2) Yes	67	0.58 (0.22, 1.58)	0.26
Disease stage			< 0.0001
(1) Early	33	1.00 ^a
(2) Intermediate	69	0.90 (0.23, 3.54)	0.88
(3) Advanced	54	12.59 (3.09, 51.32)	0.0004
Recipient age categories			0.0059
(1) < 5 years	46	1.00 ^a
(2) 6-10 years	32	0.40 (0.13, 1.28)	0.12
(3) 11-15 years	47	0.12 (0.04, 0.39)	0.0005
(4) 16-17.9 years	31	0.12 (0.02, 0.65)	0.014
Transplant year group
1999 - 2003	64	1.00 ^a
1990 - 1998	92	0.14 (0.13, 0.73)	0.0075

Reference group.

Acute GVHD III-IV is treated as a time-dependent variable.